Company / PP&E (Net)
CAPRICOR THERAPEUTICS, INC. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$18.3M
FY2025
5-year range
$1.8M / $18.3M
FY2021-FY2025
Trend
+229.3%
vs FY2024
Sector context
#82 of 195
Health Care
What the data says
PP&E (Net) changed +229% YoY in FY2025, a notable deviation from the 9-year average annual change of +70%.
Based on SEC 10-K filings.
$18M in FY2025 with a 5-year CAGR of +84.7%.
Improved from $6M to $18M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +58.6%
- 5-Year CAGR
- +84.7%
- 10-Year CAGR
- -
Sector benchmark
#82 of 195 in Health CareTop 42% of 195This company $18.3M Sector average $771.3M
▼
-97.6% below sector average
Key checks
Key Insights
- CAPRICOR THERAPEUTICS, INC.'s pp&e (net) has grown for 6 consecutive years.
- 5-year CAGR of +84.7%, indicating consistent growth.
- In FY2025, pp&e (net) increased 229.3% year-over-year.
- Ranks #82 out of 195 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.3M | +229.3% |
| FY2024 | $5.6M | +0.0% |
| FY2023 | $5.6M | +21.2% |
| FY2022 | $4.6M | +155.5% |
| FY2021 | $1.8M | +111.0% |
| FY2020 | $850.8K | +92.1% |
| FY2019 | $442.8K | -22.9% |
| FY2018 | $574.2K | +54.3% |
| FY2017 | $372.1K | -14.5% |
| FY2016 | $435.3K | +36.7% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026